# Protein arginine methylation regulates anti-inflammatory programming in response to aging stress

**Authors:** Yao Yuan, Kaori Motomura, Jun-Dal Kim, Kowit Hengphasatporn, Koichiro Kako, Syunsuke Maruhashi, Fumiya Kasai, Hayase Mizukami, Sachiko Toma-Fukai, Masafumi Muratani, Yasuteru Shigeta, Hiroaki Daitoku, Akiyoshi Fukamizu

PMC · DOI: 10.1016/j.isci.2025.113095 · iScience · 2025-07-10

## TL;DR

This study shows that human PRMT1 has higher activity than mouse PRMT1, and humanized mice with this enzyme show reduced inflammation with age.

## Contribution

Humanized PRMT1 mice reveal a novel role for PRMT1 in modulating anti-inflammatory responses during aging.

## Key findings

- Human PRMT1 has higher methyltransferase activity than mouse PRMT1 due to a single amino acid difference.
- Humanized PRMT1 mice show reduced pro-inflammatory responses with age.
- Old humanized mice are more resilient to LPS-induced inflammation.

## Abstract

PRMT1 is a key enzyme responsible for protein arginine methylation, which regulates various cellular processes. However, its physiological significance at whole-body level remains unknown due to embryonic lethality of Prmt1-null mice. Despite only one amino acid difference at position 179, molecular dynamics simulations and biochemical assays showed that human PRMT1 exhibits enhanced methyltransferase activity compared to its mouse counterpart. Capitalizing on this finding, we generated humanized PRMT1 knock-in mice (huMice) carrying the H179Y substitution. Notably, huMice displayed distinct transcriptomic signatures associated with attenuated inflammatory responses compared to wild-type mice in an age-dependent manner. In particular, huMice exhibited reduced pro-inflammatory cytokines production following lipopolysaccharide (LPS) challenge at 12 months, revealing that heightened PRMT1 activity confers a physiological advantage in alleviating age-related inflammatory stress. Our findings underscore PRMT1’s key role in the modulation of anti-inflammatory programming at the organismal level and open avenues for leveraging this knowledge in developing mitigation strategies against inflammaging.

•Human PRMT1 (hPRMT1) shows higher enzymatic activity than mouse PRMT1 (mPRMT1)•A single amino acid difference underlies the catalytic advantage of hPRMT1•Humanized PRMT1 mice (huMice) show transcriptomic signatures of stress resistance•Old huMice exhibit increased resilience to LPS-induced systemic inflammation

Human PRMT1 (hPRMT1) shows higher enzymatic activity than mouse PRMT1 (mPRMT1)

A single amino acid difference underlies the catalytic advantage of hPRMT1

Humanized PRMT1 mice (huMice) show transcriptomic signatures of stress resistance

Old huMice exhibit increased resilience to LPS-induced systemic inflammation

Epigenetics; Immunology; Transcriptomics

## Linked entities

- **Genes:** PRMT1 (protein arginine methyltransferase 1) [NCBI Gene 3276]
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** PRMT1 (protein arginine methyltransferase 1) [NCBI Gene 3276] {aka ANM1, HCP1, HRMT1L2, IR1B4}, Cdkn2a (cyclin dependent kinase inhibitor 2A) [NCBI Gene 12578] {aka ARF-INK4a, Arf, INK4a-ARF, Ink4a/Arf, MTS1, Pctr1}, Histone H4 [NCBI Gene 102641229], PRMT2 (protein arginine methyltransferase 2) [NCBI Gene 3275] {aka HRMT1L1}, EWSR1 (EWS RNA binding protein 1) [NCBI Gene 2130] {aka EWS, EWS-FLI1}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, Glb1 (galactosidase, beta 1) [NCBI Gene 12091] {aka Bge, Bgl, Bgl-e, Bgl-s, Bgl-t, Bgs}, H4C6 (H4 clustered histone 6) [NCBI Gene 8361] {aka H4, H4/c, H4FC, HIST1H4F}, PRMT5 (protein arginine methyltransferase 5) [NCBI Gene 10419] {aka HRMT1L5, HSL7, IBP72, JBP1, SKB1, SKB1Hs}, Prm1 (protamine 1) [NCBI Gene 19118] {aka Prm-1}, Ewsr1 (Ewing sarcoma breakpoint region 1) [NCBI Gene 14030] {aka Ews, Ewsh}, PRMT6 (protein arginine methyltransferase 6) [NCBI Gene 55170] {aka HRMT1L6}, Foxo1 (forkhead box O1) [NCBI Gene 56458] {aka Afxh, FKHR, Fkhr1, Foxo1a}, PRMT8 (protein arginine methyltransferase 8) [NCBI Gene 56341] {aka HRMT1L3, HRMT1L4}, Lipa (lysosomal A, lysosomal acid type) [NCBI Gene 16889] {aka Lal, Lip-1, Lip1}, Prmt1 (protein arginine N-methyltransferase 1) [NCBI Gene 15469] {aka 6720434D09Rik, Hrmt1l2, Mrmt1}, PRMT7 (protein arginine methyltransferase 7) [NCBI Gene 54496] {aka SBIDDS}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Pik3ca (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 18706] {aka 6330412C24Rik, caPI3K, p110, p110alpha}, PRMT9 (protein arginine methyltransferase 9) [NCBI Gene 90826] {aka PRMT10}, CARM1 (coactivator associated arginine methyltransferase 1) [NCBI Gene 10498] {aka PRMT4}, PRMT3 (protein arginine methyltransferase 3) [NCBI Gene 10196] {aka HRMT1L3}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Cdkn1a (cyclin dependent kinase inhibitor 1A) [NCBI Gene 12575] {aka CAP20, CDKI, CIP1, Cdkn1, P21, SDI1}
- **Diseases:** mammary gland (MESH:D005348), tumorigenesis (MESH:D063646), age (MESH:D019588), neurodegenerative disorders (MESH:D019636), Cytotoxicity (MESH:D064420), embryonic lethality (MESH:D020964), organ failure (MESH:D009102), systemic (MESH:D015619), death (MESH:D003643), cholesteryl ester storage disease (MESH:C531854), cardiovascular disease (MESH:D002318), metabolic syndrome (MESH:D024821), inflammation (MESH:D007249)
- **Chemicals:** ADMA (MESH:C018524), DAPI (MESH:C007293), WST-8 (MESH:C476329), phosphate (MESH:D010710), Na+ (MESH:D012964), 4,4-Difluoro-1,3,5,7,8-pentamethyl-4-bora-3a,4a-diaza-s-indacene (MESH:C527198), formic acid (MESH:C030544), [3H (MESH:D014316), Glutathione (MESH:D005978), BODIPY (MESH:C095489), magnesium (MESH:D008274), nitrogen compound (MESH:D017672), IPTG (MESH:D007544), calcium (MESH:D002118), SDMA (MESH:C024917), glucose (MESH:D005947), acetonitrile (MESH:C032159), EDTA (MESH:D004492), Coomassie blue (MESH:C048139), Saline (MESH:D012965), methanol (MESH:D000432), penicillin (MESH:D010406), GST (MESH:C059555), SA (MESH:D000077145), TFA (MESH:D014269), S-adenosylmethionine (MESH:D012436), MMA (MESH:D019323), RGG (-), HCl (MESH:D006851), Agarose (MESH:D012685), lipid (MESH:D008055), Tyr (MESH:D014443), TB (MESH:D013725), LPS (MESH:D008070), SDS (MESH:D012967), Dioxane (MESH:C025223), paraformaldehyde (MESH:C003043), thiogalactopyranoside (MESH:D013862), tetrazolium salt (MESH:D013778), chloroform (MESH:D002725), Arginine (MESH:D001120), Hydrogen (MESH:D006859), Histidine (MESH:D006639), PBS (MESH:D007854), nitrogen (MESH:D009584), water (MESH:D014867), BCA (MESH:C047117), CBB (MESH:C004692), CO2 (MESH:D002245), isoflurane (MESH:D007530), amino acid (MESH:D000596), Triton X-100 (MESH:D017830), streptomycin (MESH:D013307), imidazole (MESH:C029899), Alexa Fluor 555 (MESH:C000608607)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mycoplasma (genus) [taxon 2093], Escherichia coli O55 (serogroup) [taxon 2170726], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** H274Y, D11131H, H1047Y, H at position 179, His->Tyr, H179Y, R045A, H179Y, Y179
- **Cell lines:** MEF — Mus musculus (Mouse), Finite cell line (CVCL_9115), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), BL21-CodonPlus (DE3)-RIL — Mus musculus (Mouse), Hepatocellular carcinoma of the mouse, Cancer cell line (CVCL_B7TK), huMice — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_KV98), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12312054/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12312054/full.md

## References

73 references — full list in the complete paper: https://tomesphere.com/paper/PMC12312054/full.md

---
Source: https://tomesphere.com/paper/PMC12312054